Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001123343-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 16, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
24,000
Total Value
$459,200.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 14, 2026 | Exercise/Conversion | 8,000 | $16.33 | $130,640.00 | 65,500 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 14, 2026 | Sale | 8,000 | $41.07 | $328,560.00 | 57,500 | Direct | โ | View Details | |
Director | Stock option (right to buy) | Derivative | Apr 14, 2026 | Exercise/Conversion | 8,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |